Zobrazeno 1 - 10 of 137 pro vyhledávání: '"Am, Tershakovec"'
3
Report
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT.
Autor: Shah NP; Duke University School of Medicine Durham NC USA.; Duke Clinical Research Institute NC Durham USA., McGuire DK; University of Texas Southwestern Medical Center Dallas TX USA.; Parkland Health and Hospital System Dallas TX USA., Cannon CP; TIMI Study Group, Brigham and Women's Hospital Boston MA USA., Giugliano RP; TIMI Study Group, Brigham and Women's Hospital Boston MA USA., Lokhnygina Y; Duke University School of Medicine Durham NC USA.; Duke Clinical Research Institute NC Durham USA., Page CB; Duke Clinical Research Institute NC Durham USA., Tershakovec AM; Merck & Co., Inc. Kenilworth NJ USA., Braunwald E; TIMI Study Group, Brigham and Women's Hospital Boston MA USA., Blazing MA; Duke University School of Medicine Durham NC USA.; Duke Clinical Research Institute NC Durham USA.
Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2023 Jul 04; Vol. 12 (13), pp. e029593. Date of Electronic Publication: 2023 Jun 22.
Zobrazit plný text záznamu
4
Akademický článek
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
Autor: Oyama K; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: https://twitter.com/KazumaOyama., Giugliano RP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: rgiugliano@bwh.harvard.edu., Blazing MA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA., Park JG; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Tershakovec AM; Merck and Co, Inc, Kenilworth, New Jersey, USA., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Cannon CP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: https://twitter.com/cpcannon., Braunwald E; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Oct 12; Vol. 78 (15), pp. 1499-1507.
Zobrazit plný text záznamu
5
Akademický článek
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT.
Autor: Giugliano RP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Gencer B; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Wiviott SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Park JG; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Fuchs CS; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Goessling W; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA., Musliner TA; Merck, Kenilworth, New Jersey, USA., Tershakovec AM; Merck, Kenilworth, New Jersey, USA., Blazing MA; Duke Clinical Research Institute, Durham, North Carolina, USA., Califf R; Verily Life Sciences and Google Health, South San Francisco, California, USA., Cannon CP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Braunwald E; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2020 Sep 15; Vol. 2 (3), pp. 385-396. Date of Electronic Publication: 2020 Sep 15 (Print Publication: 2020).
Zobrazit plný text záznamu
6
Editorial & Opinion
Author response: The human cough reflex has separate, distinct pathways.
Autor: Morice AH; Hull York Medical School, Cottingham, UK a.h.morice@hull.ac.uk., Kitt MM; Merck & Co., Inc., Kenilworth, NJ, USA., Ford AP; Merck & Co., Inc., Kenilworth, NJ, USA., Tershakovec AM; Merck & Co., Inc., Kenilworth, NJ, USA., Wu WC; Merck & Co., Inc., Kenilworth, NJ, USA., Brindle K; Hull York Medical School, Cottingham, UK., Thompson R; Hull York Medical School, Cottingham, UK., Thackray-Nocera S; Hull York Medical School, Cottingham, UK., Wright C; Hull York Medical School, Cottingham, UK.
Publikováno v: The European respiratory journal [Eur Respir J] 2020 Feb 06; Vol. 55 (2). Date of Electronic Publication: 2020 Feb 06 (Print Publication: 2020).
Zobrazit plný text záznamu
7
Akademický článek
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
Autor: Toth PP; CGH Medical Center, Sterling, IL, USA; Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: Peter.Toth@cghmc.com., Bays HE; Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA., Brown WV; Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Catapano AL; Department of Pharmacological and Biomolecular Sciences, University of Milan, Multimedica IRCCS, Milan, Italy., Davidson MH; The University of Chicago, Pritzker School of Medicine, Chicago, IL, USA., Farnier M; Lipid Clinic, Point Médical, and Departement of Cardiology, CHU Dijon-Bourgogne, Dijon, France., Tomassini JE; Global Clinical Development, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, NJ, USA., Jensen E; Global Clinical Development, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, NJ, USA., Polis AB; Global Clinical Development, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, NJ, USA., Tershakovec AM; Global Clinical Development, Merck Research Laboratories, Merck & Co, Inc, Kenilworth, NJ, USA.
Publikováno v: Journal of clinical lipidology [J Clin Lipidol] 2019 Nov - Dec; Vol. 13 (6), pp. 997-1007.e8. Date of Electronic Publication: 2019 Sep 11.
Zobrazit plný text záznamu
8
Akademický článek
The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study.
Autor: Morice AH; Hull York Medical School, Cottingham, UK., Kitt MM; Merck & Co., Inc., Kenilworth, NJ, USA., Ford AP; Merck & Co., Inc., Kenilworth, NJ, USA., Tershakovec AM; Merck & Co., Inc., Kenilworth, NJ, USA., Wu WC; Merck & Co., Inc., Kenilworth, NJ, USA., Brindle K; Hull York Medical School, Cottingham, UK., Thompson R; Hull York Medical School, Cottingham, UK., Thackray-Nocera S; Hull York Medical School, Cottingham, UK., Wright C; Hull York Medical School, Cottingham, UK.
Publikováno v: The European respiratory journal [Eur Respir J] 2019 Jul 04; Vol. 54 (1). Date of Electronic Publication: 2019 Jul 04 (Print Publication: 2019).
Zobrazit plný text záznamu
9
Akademický článek
Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs.
Autor: Li H; Department of Statistics, University of Connecticut, Storrs, CT, USA., Chen MH; Department of Statistics, University of Connecticut, Storrs, CT, USA., Ibrahim JG; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA., Kim S; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Shah AK; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, USA., Lin J; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, USA., Tershakovec AM; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, USA.
Publikováno v: Biostatistics (Oxford, England) [Biostatistics] 2019 Jul 01; Vol. 20 (3), pp. 499-516.
Zobrazit plný text záznamu
10
Akademický článek
Medication Discontinuation in the IMPROVE-IT Trial.
Autor: Navar AM; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.).; Duke Forge, Duke University, Durham, NC (A.M.N., R.M.C.)., Roe MT; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.)., White JA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.)., Cannon CP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (C.P.C., R.P.G., E.B.)., Lokhnygina Y; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.)., Newby LK; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.)., Giugliano RP; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.).; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (C.P.C., R.P.G., E.B.)., Tershakovec AM; Merck & Co, Inc, Rahway, NJ (A.M.T.)., Braunwald E; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (C.P.C., R.P.G., E.B.)., Califf RM; Duke Forge, Duke University, Durham, NC (A.M.N., R.M.C.).; Department of Medicine, Stanford University, CA (R.M.C.).; Verily Life Sciences, South San Francisco, CA (R.M.C.)., Blazing MA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.).
Publikováno v: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2019 Jan; Vol. 12 (1), pp. e005041.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje